Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00118274
Status:
COMPLETED
Last Update Posted:
2021-04-20
First Post:
2005-07-08
Brief Title:
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II Stage III or Stage IV Melanoma
Sponsor:
Craig L Slingluff Jr
Organization:
University of Virginia
Organization Data
Organization:
University of Virginia
Class:
OTHER
Study ID:
11491
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Craig L Slingluff Jr
Lead Sponsor Class:
OTHER
Responsible Party:
Craig L Slingluff Jr
Responsible Party Title:
Professor of Surgery
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Virginia
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |